[Form 4] National Vision Holdings, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Insider sales by Executive Chairman Fahs L. Reade were disclosed on Form 4 for National Vision Holdings, Inc. (EYE). The filing reports two separate open-market sales executed on 08/28/2025 under a Rule 10b5-1 trading plan established May 28, 2025, totaling 137,400 shares sold at weighted-average prices of $23.85 and $24.76. After the transactions the reporting person is shown with directly beneficial ownership of 617,525 shares on one line and 544,795 shares on another line, and indirect beneficial ownership of 363,430 shares held by a trust. The Form 4 was signed by an attorney-in-fact.

Positive

• None.

Negative

• Insider sold 137,400 shares in open-market transactions on 08/28/2025, reducing direct beneficial ownership.
• Post-transaction direct holdings decreased as shown by reported direct ownership figures (617,525 and 544,795 shares on reported lines).

Insights

Financial Analyst

TL;DR: Executive Chairman sold 137,400 shares under a pre-existing 10b5-1 plan; transaction is documented and routine but reduces his direct stake.

The Form 4 shows two open-market dispositions on 08/28/2025 totaling 137,400 shares sold pursuant to a Rule 10b5-1 plan established 05/28/2025, with weighted-average sale prices of $23.85 and $24.76. The filing lists differing post-transaction direct ownership amounts (617,525 and 544,795 shares) and an indirect holding of 363,430 shares via trust. These sales are explicitly recorded and executed under the trading plan; no options or derivative transactions are reported. For investors, this is a documented insider liquidity event rather than a corporate action or financial restatement.

Corporate Governance Expert

TL;DR: The sales followed a Rule 10b5-1 plan, indicating pre-arranged trades; disclosure is compliant but reduces the chair's reported direct holdings.

The disclosure identifies Fahs L. Reade as Executive Chairman and Director and states the sales were effected under a 10b5-1 plan dated May 28, 2025. The filing provides weighted-average prices and notes multiple transactions across price ranges, with the filer offering to provide breakdowns to the SEC upon request. The Form 4 was executed by an attorney-in-fact, consistent with authorized signatory practice. This is a governance-compliant insider sale, materially reducing reported direct share counts but accompanied by explicit plan disclosure.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FAHS L READE

(Last) (First) (Middle)

C/O NATIONAL VISION HOLDINGS, INC.,

2435 COMMERCE AVENUE, BLDG. 2200

(Street)

DULUTH GA 30096-4980

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
National Vision Holdings, Inc. [ EYE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Chairman

3. Date of Earliest Transaction (Month/Day/Year)
08/28/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/28/2025		S		64,670(1)	D	$23.85(2)	617,525	D
Common Stock	08/28/2025		S		72,730(1)	D	$24.76(3)	544,795	D
Common Stock								363,430	I	Held by Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 28, 2025.

2. Price represents the weighted average sales price. The shares were sold in multiple transactions as prices ranging from $23.39 to $24.38. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.

3. Price represents the weighted average sales price. The shares were sold in multiple transactions as prices ranging from $24.41 to $24.90. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.

Remarks:

	/s/ Jared Brandman, as Attorney-in-Fact	08/29/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Fahs L. Reade report on the Form 4 for National Vision Holdings (EYE)?

The Form 4 reports two open-market sales on 08/28/2025 totaling 137,400 shares sold under a Rule 10b5-1 plan.

Were the sales effected under a pre-arranged trading plan?

Yes. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan established May 28, 2025.

What prices were reported for the shares sold?

The filing reports weighted-average prices of $23.85 and $24.76; underlying transactions ranged from $23.39 to $24.90 across multiple trades.

How much beneficial ownership does the reporting person retain according to the Form 4?

The Form 4 shows direct beneficial ownership amounts of 617,525 and 544,795 on reported lines and indirect ownership of 363,430 shares held by a trust.

Who signed the Form 4 filing?

The Form 4 was signed by /s/ Jared Brandman, as Attorney-in-Fact on 08/29/2025.